Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.06	40.58	22.35	32.55	45.75	74.59
Short-Term Investments	-	-	80.4	65.34	-	-
Cash & Short-Term Investments	22.06	40.58	102.75	97.89	45.75	74.59
Cash Growth	-57.28%	-60.51%	4.96%	113.99%	-38.67%	660.53%
Other Current Assets	0.96	2.45	2.07	2.94	2.17	1.32
Total Current Assets	23.02	43.03	104.82	100.83	47.92	75.92
Net Property, Plant & Equipment	18.7	21.33	35.28	4.47	5.86	4.47
Other Long-Term Assets	1.99	1.99	2.5	4.67	1.09	0.45
Total Assets	43.71	66.35	142.6	109.97	54.87	80.83

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	0.63	1.18	3.13	2.62	3.13	0.92
Accrued Expenses	1.1	2.59	9.37	9.03	4.26	2.98
Current Portion of Leases	4.68	4.12	5.43	1.55	1.07	0.99
Unearned Revenue	0.01	0.4	1.66	1.28	9.79	-
Other Current Liabilities	3.06	4.35	-	-	-	-
Total Current Liabilities	9.48	12.63	19.6	14.47	18.25	4.88
Long-Term Leases	26.7	30.26	21.45	0.67	0.38	1.45
Other Long-Term Liabilities	11.86	11.86	12.14	14.08	1.93	-
Total Long-Term Liabilities	38.56	42.12	33.58	14.74	2.31	1.45
Total Liabilities	48.04	54.75	53.18	29.21	20.55	6.34

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0	0	0.06	0.03	0.01	0.01
Additional Paid-in Capital	422.43	416.38	400.69	329.39	227.7	224.36
Accumulated Other Comprehensive Income	-	-	0.03	0.01	-	-
Retained Earnings	-426.76	-404.79	-311.36	-248.68	-193.4	-149.88
Total Common Shareholders' Equity	-4.33	11.59	89.42	80.75	34.32	74.49
Shareholders' Equity	-4.33	11.59	89.42	80.75	34.32	74.49
Total Liabilities & Equity	43.71	66.35	142.6	109.97	54.87	80.83

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	31.38	34.38	26.88	2.22	1.45	2.44
Net Cash (Debt)	-9.32	6.2	75.87	95.68	44.29	72.15
Net Cash Growth	-	-91.83%	-20.70%	116.01%	-38.61%	1013.14%
Net Cash Per Share	-6.50	4.76	76.17	158.22	170.54	419.98
Book Value	-4.33	11.59	89.42	80.75	34.32	74.49
Book Value Per Share	-3.02	8.90	89.77	133.54	132.13	433.59
Tangible Book Value	-4.33	11.59	89.42	80.75	34.32	74.49
Tangible Book Value Per Share	-3.02	8.90	89.77	133.54	132.13	433.59

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error